Gilead's Win Upheld In Billion-Dollar HIV Drug Patent Case
By Hailey Konnath · March 22, 2024, 11:31 PM EDT
A Delaware federal judge on Friday largely upheld a jury's verdict rejecting the government's potentially billion-dollar claim that Gilead Sciences Inc. infringed patents covering HIV drugs, ruling that the jury was...
To view the full article, register now.